The use of PLGF based tests in suspected pre-eclampsia
Placental growth factor (PlGF) is a protein involved in placental angiogenesis (the development of new blood vessels). In pre-eclampsia, levels of PlGF can be abnormally low.
The PHOENIX trial is a non-masked, randomised controlled trial, comparing planned early delivery with usual care in women with pre-eclampsia between 34+0 and 36+6 weeks’ gestation.
Reducing maternal deaths from hypertensive disorders
Confidential inquiries into maternal deaths in the UK were established in 1952 and have aimed to report on every pregnancy related death since then.
Placental growth factor testing
Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.
Cradle VSA Blood Pressure Monitor
Find out more about the world’s first medical device to detect shock and high blood pressure in pregnant women that could cut maternal deaths in developing countries by up to 25%, saving more than 70,000 lives a year.